SCHEMBL5745552

SCHEMBL5745552

O=C(O)C1(C(=O)O)CNC1

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.32
GRM2 Q14416 1/20 0.30
GRM3 Q14832 1/20 0.30
CYP1A2 P05177 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2873835 0.77 HTR2A (0.32) FFAR3
Trifluoroacetic Acid SCHEMBL18740355 0.76 SLC1A2 (0.35) CYP1A2
SCHEMBL29102688 0.73 HSD17B10 (0.33)
SCHEMBL6900137 0.72
SCHEMBL19730748 0.71
SCHEMBL18756397 0.71 FFAR3 (0.30) FFAR3
SCHEMBL1668813 0.71
SCHEMBL19689587 0.71 KDM4E (0.34)
Hydrochloric Acid SCHEMBL1488612 0.69
SCHEMBL825722 0.69 KDM4E (0.38) FFAR3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119118894-A TRPV4 receptor ligands 犹他大学研究基金会 2024-12-13 CN disclosed
EP-4108675-A1 PREPARATION AND USE OF IMMUNOSTIMULATORY COUPLING COMPLEX WHICH IS DELIVERED AND ACTIVATED IN TARGETED MANNER Yafei Shanghai Biolog Medicine Science & Technology Co., Ltd. (CN) 2022-12-28 EP disclosed
CN-105061350-B The sphingosine 1-phosphate receptor modulators and Chiral Synthesis of selectivity 赛尔基因第二国际有限公司 2018-05-29 CN disclosed
EP-2409704-A2 c-Met modulators and methods of use Exelixis Inc. (US) 2012-01-25 EP disclosed
EP-2392565-A1 c-Met modulators and methods of use Exelixis Inc. (US) 2011-12-07 EP disclosed
EP-2392564-A1 c-Met modulators and methods of use Exelixis Inc. (US) 2011-12-07 EP disclosed
EP-1673085-B1 C-MET MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2011-11-09 EP disclosed
EP-2210607-B1 N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer EXELIXIS INC (US) 2011-08-17 EP disclosed
EP-2213661-B1 c-Met Modulators and Methods of Use EXELIXIS INC (US) 2011-07-20 EP disclosed
EP-2213661-A1 c-Met Modulators and Methods of Use Exelixis Inc. (US) 2010-08-04 EP disclosed
US-4855452-A N-substituted azetidine carboxylate derivatives SHELL OIL COMPANY (US) 1989-08-08 US disclosed
US-4778577-A OXIDATION OF ALCOHOL TO ACID WITH NICKEL/III/COMPOUND SHELL OIL COMPANY (US) 1988-10-18 US disclosed
EP-0165636-B1 PROCESS FOR PREPARING AZETIDINE DERIVATIVES AND INTERMEDIATES THEREIN SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-08-10 EP disclosed
EP-0165637-B1 AZETIDINE DERIVATIVES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-07-27 EP disclosed
US-4665197-A NITRIC ACID OXIDATION OF 3,3-BIS/HYDROXYMETHYL/AZETIDINE/ SHELL OIL COMPANY (US) 1987-05-12 US disclosed
CN-86102422-A The method for preparing azetidine derivatives 1987-01-28 CN disclosed
EP-0201957-A2 Process for the preparation of a carboxylic acid salt SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1986-11-20 EP disclosed
EP-0199413-A2 Process for preparing azetidine derivatives and novel intermediates therein SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1986-10-29 EP disclosed
EP-0165637-A1 Azetidine derivatives SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1985-12-27 EP disclosed
EP-0165636-A1 Process for preparing azetidine derivatives and intermediates therein SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1985-12-27 EP disclosed